Veterinary Medicines

Ingelvac Aujeszky MLV plus

Authorised
  • Aujeszky's disease virus, strain Bartha K61, Live
Download as PDF

Product identification

Medicine name:
Ingelvac Aujeszky MLV plus
Active substance:
  • Aujeszky's disease virus, strain Bartha K61, Live
Target species:
  • Pig
  • Pig (piglet)
Route of administration:
  • Intradermal use
  • Nasal use
  • Intramuscular use

Product details

Active substance and strength:
  • Aujeszky's disease virus, strain Bartha K61, Live
    19952600.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intradermal use
    • Pig
      • Meat and offal
        7
        day
    • Pig (piglet)
      • Meat and offal
        7
        day
  • Nasal use
    • Pig
      • Meat and offal
        7
        day
    • Pig (piglet)
      • Meat and offal
        7
        day
  • Intramuscular use
    • Pig
      • Meat and offal
        7
        day
    • Pig (piglet)
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 320a/93
Date of authorisation status change: